⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AKBA News
Akebia Therapeutics, Inc.
AKBA ALERT: Levi & Korsinsky Investigates Akebia Therapeutics, Inc. on Behalf of Shareholders Who Lost Money
accessnewswire.com
AKBA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akebia Therapeutics, Inc. - AKBA
accessnewswire.com
AKBA
Lost Money on Akebia Therapeutics, Inc. (AKBA)? Contact Levi & Korsinsky About Investigation
accessnewswire.com
AKBA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akebia Therapeutics, Inc. - AKBA
accessnewswire.com
AKBA
Lost Money on Akebia Therapeutics, Inc. (AKBA)? Contact Levi & Korsinsky to Protect Your Rights
accessnewswire.com
AKBA
Akebia Therapeutics, Inc. (AKBA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
AKBA
ATTENTION Akebia Therapeutics, Inc. (AKBA) Investors: Possible Fraud - Contact Levi & Korsinsky Today
accessnewswire.com
AKBA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akebia Therapeutics, Inc. - AKBA
accessnewswire.com
AKBA
Vafseo® (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs
globenewswire.com
AKBA
Securities Investigation: Levi & Korsinsky Investigates Akebia Therapeutics, Inc. (AKBA) on Behalf of Investors
accessnewswire.com
AKBA